Rhythm Pharmaceuticals, Inc. Insider Trading Activity
Accepted by SEC EDGAR
Learn about SEC filing dates
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Insider Trade Summary
Exercise and sale activity reported; no spread calculated
Exercise and Sale
4 txns
Insider
Garfield Alastair
Role
Chief Scientific Officer
Sold
1,319 shs ($85K)
Approx. gross sale proceeds
$85K
Approx. exercise cost
$0.00
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 1,313 | $64.81 | $85K |
| Sale | Common Stock | 6 | $64.60 | $387.60 |
| Exercise | Restricted Stock Units | 4,445 | $0.00 | $0.00 |
| Exercise | Common Stock | 4,445 | $0.00 | $0.00 |
Holdings After Transaction:
Restricted Stock Units — 13,333 units (Direct);
Common Stock — 3,126 shares (Direct)
Footnotes (3)
- F1. Each restricted stock unit represents a contingent right to receive one share of Issuer common stock.
- F2. The sale reported in this Form 4 was effected pursuant to Rule 10b5-1 instruction adopted on June 25, 2024 solely with the intent to cover withholding taxes in connection with the vesting of certain previously reported restricted stock units.
- F3. The restricted stock units vest as to 25% of the total restricted stock units on each of the first four anniversaries of July 1, 2024, subject to the Reporting Person's continued service on each such vesting date. The restricted stock units have no expiration date.
AI-generated analysis. How Rhea-AI works. Not financial advice.